Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bostjan Seruga

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Nature Reviews. Clinical Oncology|April 1, 2010
Medical oncology: Zoledronic acid for breast cancer therapy-induced bone lossEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Cancer Treatment Reviews|June 19, 2012
The evolving landscape of protein kinases in breast cancer: clinical implicationsAlberto Ocaña, Eitan Amir, Bostjan Seruga, et al.
Radiology and Oncology|December 2, 2016
Outcome of severe infections in afebrile neutropenic cancer patientsKsenija Strojnik, Ksenija Mahkovic-Hergouth, Barbara Jezersek Novakovic, et al.
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: dose-dense treatment for triple-negative breast cancerEitan Amir, Alberto Ocana, Orit Freedman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2011
Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?Eitan Amir, Bostjan Seruga, Ryan Kwong, et al.
Radiology and Oncology|July 6, 2026
Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic reviewAnja Urbas, Polona Usaj, Bostjan Seruga, et al.
Mayo Clinic Proceedings|January 7, 2019
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled TrialsDaniel Shepshelovich, Ariadna Tibau, Hadar Goldvaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
Phase III trials of targeted anticancer therapies: redesigning the conceptAlberto Ocana, Eitan Amir, Francisco Vera-Badillo, et al.
Nutrition and Cancer|February 12, 2021
Nutritional Status and Health-Related Quality of Life in Men with Advanced Castrate-Resistant Prostate CancerLuka Cavka, Maja Pohar Perme, Branko Zakotnik, et al.
Oncology|November 20, 2017
Reporting of Randomized Trials in Common Cancers in the Lay MediaDomen Ribnikar, Hadar Goldvaser, Alberto Ocana, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Nature Reviews. Clinical Oncology|April 1, 2010
Medical oncology: Zoledronic acid for breast cancer therapy-induced bone lossEitan Amir, Alberto Ocaña, Bostjan Seruga, et al.
Cancer Treatment Reviews|June 19, 2012
The evolving landscape of protein kinases in breast cancer: clinical implicationsAlberto Ocaña, Eitan Amir, Bostjan Seruga, et al.
Radiology and Oncology|December 2, 2016
Outcome of severe infections in afebrile neutropenic cancer patientsKsenija Strojnik, Ksenija Mahkovic-Hergouth, Barbara Jezersek Novakovic, et al.
Nature Reviews. Clinical Oncology|February 2, 2010
Chemotherapy: dose-dense treatment for triple-negative breast cancerEitan Amir, Alberto Ocana, Orit Freedman, et al.
European Journal of Cancer (Oxford, England : 1990)|November 26, 2011
Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?Eitan Amir, Bostjan Seruga, Ryan Kwong, et al.
Radiology and Oncology|July 6, 2026
Genetic testing for cancer predisposition syndromes in pediatric cancer patients: current practices and recommendations - a systematic reviewAnja Urbas, Polona Usaj, Bostjan Seruga, et al.
Mayo Clinic Proceedings|January 7, 2019
Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled TrialsDaniel Shepshelovich, Ariadna Tibau, Hadar Goldvaser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
Phase III trials of targeted anticancer therapies: redesigning the conceptAlberto Ocana, Eitan Amir, Francisco Vera-Badillo, et al.
Nutrition and Cancer|February 12, 2021
Nutritional Status and Health-Related Quality of Life in Men with Advanced Castrate-Resistant Prostate CancerLuka Cavka, Maja Pohar Perme, Branko Zakotnik, et al.
Oncology|November 20, 2017
Reporting of Randomized Trials in Common Cancers in the Lay MediaDomen Ribnikar, Hadar Goldvaser, Alberto Ocana, et al.
Pageof 9